Company profile for Angitia Biopharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Angitia Biopharma is at the forefront of innovation in the biotechnology industry, dedicated to discovering and developing novel therapies to address unmet medical needs. Focused on advancing biologics and cutting-edge therapeutic solutions, the company combines rigorous scientific research with clinical expertise to enhance patient outcomes and contribute to global healthcare advancements. With a commitment to quality, safe...
Angitia Biopharma is at the forefront of innovation in the biotechnology industry, dedicated to discovering and developing novel therapies to address unmet medical needs. Focused on advancing biologics and cutting-edge therapeutic solutions, the company combines rigorous scientific research with clinical expertise to enhance patient outcomes and contribute to global healthcare advancements. With a commitment to quality, safety, and efficacy, Angitia Biopharma is shaping the future of medicine by delivering transformative solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
188 Kaiyuan Avenue, 2F, Building 4, Guangzhou, Guangdong 510530
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/08/3146019/0/en/Angitia-Biopharmaceuticals-Presents-First-in-Human-Data-on-AGA2115-for-Osteogenesis-Imperfecta-at-ASBMR-2025.html

GLOBENEWSWIRE
08 Sep 2025

https://www.globenewswire.com/news-release/2025/08/19/3135605/0/en/Angitia-Biopharmaceuticals-to-Present-Data-on-AGA2115-for-Osteogenesis-Imperfecta-at-ASBMR-2025.html

GLOBENEWSWIRE
19 Aug 2025

https://www.globenewswire.com/news-release/2025/06/12/3098209/0/en/Angitia-Biopharmaceuticals-Announces-Topline-Results-from-First-in-Human-Study-of-AGA2115-A-Bispecific-Antibody-for-the-Treatment-of-Osteogenesis-Imperfecta.html

GLOBENEWSWIRE
12 Jun 2025

https://www.globenewswire.com//news-release/2025/03/18/3044330/0/en/Angitia-Biopharmaceuticals-Presents-Data-from-Phase-1-2-Study-of-AGA111-at-2025-AAOS-Annual-Meeting.html

GLOBENEWSWIRE
18 Mar 2025

https://www.globenewswire.com/news-release/2025/01/08/3006150/0/en/Angitia-Biopharmaceuticals-to-Present-at-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html

GLOBENEWSWIRE
08 Jan 2025

https://www.globenewswire.com/news-release/2024/12/11/2995375/0/en/Angitia-Biopharmaceuticals-Announces-120-Million-Series-C-Financing.html

GLOBENEWSWIRE
11 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty